Back to Search
Start Over
Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial.
- Source :
- JAMA Neurology; Oct2022, Vol. 79 Issue 10, p1015-1024, 10p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 21686149
- Volume :
- 79
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- JAMA Neurology
- Publication Type :
- Academic Journal
- Accession number :
- 159683338
- Full Text :
- https://doi.org/10.1001/jamaneurol.2022.2793